Chondrial Therapeutics Holdings, Llc - Net Worth and Insider Trading

Chondrial Therapeutics Holdings, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chondrial Therapeutics Holdings, Llc owns 1 companies in total, including Larimar Therapeutics Inc (LRMR) .

Click here to see the complete history of Chondrial Therapeutics Holdings, Llc’s form 4 insider trades.

Insider Ownership Summary of Chondrial Therapeutics Holdings, Llc

Ticker	Comapny	Transaction Date	Type of Owner
LRMR	Larimar Therapeutics Inc	2020-05-28	10 percent owner

Chondrial Therapeutics Holdings, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chondrial Therapeutics Holdings, Llc Ownership Network

Ownership Network List of Chondrial Therapeutics Holdings, Llc

No Data

Ownership Network Relation of Chondrial Therapeutics Holdings, Llc

Chondrial Therapeutics Holdings, Llc Owned Company Details

What does Larimar Therapeutics Inc do?

Who are the key executives at Larimar Therapeutics Inc?

Chondrial Therapeutics Holdings, Llc is the 10 percent owner of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .

Larimar Therapeutics Inc (LRMR) Insider Trades Summary

Over the past 18 months, Chondrial Therapeutics Holdings, Llc made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Michael Celano , and a net purchase of 5,000 shares made by Carole Ben-maimon .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Larimar Therapeutics Inc Insider Transactions

No Available Data

Chondrial Therapeutics Holdings, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Chondrial Therapeutics Holdings, Llc. You might contact Chondrial Therapeutics Holdings, Llc via mailing address: 150 Monument Road, Suite 207, Bala Cynwyd Pa 19004.

Discussions on Chondrial Therapeutics Holdings, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.